Skip to main content
TipRanks
Go Ultimate75% OFF

Fusen Pharmaceutical Co., Ltd. (1652) Income Statement

0 Followers

Fusen Pharmaceutical Co., Ltd. Income Statement

Last quarter (Q2 2026), Fusen Pharmaceutical Co., Ltd.'s total revenue was ¥114.18M, a decrease of 41.84% from the same quarter last year. In Q2, Fusen Pharmaceutical Co., Ltd.'s net income was ¥-13.69M. See Fusen Pharmaceutical Co., Ltd.’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
¥ 273.37M¥ 326.03M¥ 565.61M¥ 491.76M¥ 385.66M
¥ 109.79M¥ 162.64M¥ 299.51M¥ 225.02M¥ 211.13M
¥ 111.51M¥ 230.15M¥ 279.49M¥ 186.41M¥ 146.65M
Depreciation and Amortization¥ 37.42M¥ 41.71M¥ 35.80M¥ 34.16M¥ 23.79M
¥ 11.55M¥ -25.46M¥ 18.93M¥ 49.90M¥ 55.82M
¥ -1.72M¥ -67.51M¥ 20.02M¥ 15.74M¥ 52.14M
¥ -5.88M¥ -122.94M¥ -49.46M¥ -74.75M¥ -28.35M
¥ -7.60M¥ -190.45M¥ -29.45M¥ -30.99M¥ 23.79M
¥ -11.78M¥ -188.78M¥ -36.28M¥ -34.65M¥ 16.64M
Per Share Metrics
Basic EPS¥ -0.02¥ -0.26¥ -0.05¥ -0.05¥ 0.02
Diluted EPS¥ -0.02¥ -0.26¥ -0.05¥ -0.05¥ 0.02
Weighted Average Shares Outstanding739.30M739.98M725.54M756.07M769.62M
Weighted Average Shares Outstanding (Diluted)739.30M739.98M752.06M756.07M770.31M

Currency in CNY

Fusen Pharmaceutical Co., Ltd. Earnings and Revenue History

-400M0400M800M-80 %-40 %0 %40 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin